Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129844
Status:
COMPLETED
Last Update Posted:
2008-08-20
First Post:
2005-08-10
Brief Title:
Study of Motexafin Gadolinium MGd for Second Line Treatment of Non-Small-Cell Lung Cancer
Sponsor:
Pharmacyclics LLC
Organization:
Pharmacyclics LLC
Organization Data
Organization:
Pharmacyclics LLC
Class:
INDUSTRY
Study ID:
PCYC-0227
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pharmacyclics LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None